Tag: FDA

10/13/2011

The limitations of progression-free survival as an endpoint – NPR addresses

9/15/2011

Sour apples in land of Oz as FDA rips his apple juice fear-mongering

8/16/2011

FDA publishes “Communicating Risks & Benefits: An Evidence-Based User’s Guide”

8/10/2011

Laurel & Hardy and prostate cancer chemoprevention

8/3/2011

Concerns over FDA loosening conflict of interest rules

7/11/2011

“Think Inside the Box” – call for plain English facts labels about Rx drugs

6/28/2011

Clash between data and emotion in FDA decision on Avastin for metastatic breast cancer

4/22/2011

7 health news web gems to wrap up the week

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

Retweet on Twitter HealthNewsReview.org Retweeted

National Breast Cancer Coalition @NBCCStopBC·

A lot of interesting workshops are happening now at the #NBCCSummit! @garyschwitzer, the publisher of @HealthNewsRevu, is discussing new cancer research news. #BeBold

Reply on Twitter 1520768892888567810 Retweet on Twitter 15207688928885678101 Like on Twitter 15207688928885678103 Twitter 1520768892888567810

HealthNewsReview.org @HealthNewsRevu·

Take all the issues enmeshed in any cancer screening story and amplify it with the liquid biopsy issue. @AP's ⁦@CarlaKJohnson⁩. did a solid job here. https://apnews.com/article/science-business-health-hodgkin-lymphoma-oregon-ca899bb9c4c7f1859d4e9ce16a1cf78d

Reply on Twitter 1516522980385472513 Retweet on Twitter 1516522980385472513 Like on Twitter 15165229803854725134 Twitter 1516522980385472513